In this episode of Industry Focus: Wildcard , Dylan Lewis and Motley Fool contributor Brian Feroldi do a deep dive into Outset Medical (NASDAQ: OM) , a dialysis system developer which recently came public. They discuss how Outset's system works, its advantages over traditional methods of dialysis, and why it could be a gamechanger in the space.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center . To get started investing, check out our quick-start guide to investing in stocks . A full transcript follows the video.
For further details see:
Outset Medical Is Trying to Upend Dialysis. What Should Investors Think of This IPO?